Biosurgery sealants stop bleeding in many cases where the application of ligature, pressure, and other conventional methods are ineffective. They are generally used in vascular reconstruction to accomplish mechanical hemostasis. In addition, surgical sealants are also used for suture line replacements, aortic root replacements, anastomoses and prevention of the arterial & venous bleeding. Most of commercial surgical sealants are biocompatible, flexible and biodegradable. Surgical sealants can be natural or synthetic or a mix of both. Natural surgical sealants generally include polypeptide or proteins & polysaccharides. Synthetic sealants include polyethene glycol, polyurethane and polymer adhesives respectively.
As per analysis, “Global Biosurgery Sealants Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027” the key companies operating in the global biosurgery sealants market include Cohera Medical, CR Bard, Baxter International, Medtronic, CryoLife, Johnson & Johnson, CSL Behring and among others. Leading companies developing products for surgical care are progressively more focused on exploring novel avenues in biosurgery by engaging in persistent research & development activities.
Based on types, biosurgery sealants market can be segregated as collagen sealants and fibrin sealants. In addition, based on application, market can be segregated as clinics & trauma centers, hospitals and ambulatory surgical centers. The hospital segment holds largest market share. The large market share of this segment can be attributed to increasing number of hospitals and growing infrastructural & economic development, particularly in the emerging countries. Moreover, increase in surgical procedures performed in operating rooms of hospitals also maintains high growth in the hospitals segment.
Rapid growth in geriatric population, followed by rise in concerns to decrease surgical injuries, growth in need for effective blood loss management in the patients, increase in government initiatives for the healthcare sector, well-developed healthcare sector, rise in demand for surgical services and increase in clearance of biosurgery products by regulatory authorities are some major factors, which are responsible for growth of the biosurgery sealants market. Apart from this, strict regulatory approvals, and high cost of these products may impact the market. Moreover, rise in use of technologically advanced products, growth in need for effective blood loss management in patients and rise in prominence of adhesive dentistry are leading opportunities for market. Furthermore, requirement of skilled personnel for optimal utilization of products and development of novel biomaterials are key trend for global market.
Based on regional analysis, the North-America is a leading region in global biosurgery sealants market owing to increase in volume of surgical procedures performed and presence of a well-developed healthcare system across the region. The Europe and Asia-Pacific regions are anticipated to exhibit substantial growth rate due to developed healthcare infrastructure, increase in number of hospitals coupled with presence of leading market players over the forecast period. It is projected that future of the global biosurgery sealants market will be bright on account of huge patient population of chronic diseases, increase in volume of surgeries and sports-related & trauma injuries during the forecast period.
For More Information, refer to below link:-
Global Biosurgery Sealants Industry Future Outlook 2021-2027
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
